enVVeno Medical Corp
NASDAQ:NVNO
Intrinsic Value
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular di... [ Read More ]
The intrinsic value of one NVNO stock under the Base Case scenario is hidden USD. Compared to the current market price of 5.01 USD, enVVeno Medical Corp is hidden .
Valuation Backtest
enVVeno Medical Corp
Run backtest to discover the historical profit from buying and selling NVNO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
enVVeno Medical Corp
Current Assets | 43.2m |
Cash & Short-Term Investments | 42.9m |
Other Current Assets | 306k |
Non-Current Assets | 1.6m |
PP&E | 1.6m |
Other Non-Current Assets | 31k |
Current Liabilities | 1.5m |
Accounts Payable | 604k |
Accrued Liabilities | 883k |
Non-Current Liabilities | 973k |
Other Non-Current Liabilities | 973k |
Earnings Waterfall
enVVeno Medical Corp
Revenue
|
0
USD
|
Operating Expenses
|
-23.9m
USD
|
Operating Income
|
-23.9m
USD
|
Other Expenses
|
1.8m
USD
|
Net Income
|
-22.1m
USD
|
Free Cash Flow Analysis
enVVeno Medical Corp
NVNO Profitability Score
Profitability Due Diligence
enVVeno Medical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
enVVeno Medical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
NVNO Solvency Score
Solvency Due Diligence
enVVeno Medical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
enVVeno Medical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NVNO Price Targets Summary
enVVeno Medical Corp
According to Wall Street analysts, the average 1-year price target for NVNO is 20.81 USD with a low forecast of 20.6 USD and a high forecast of 21.42 USD.
Ownership
NVNO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
NVNO Price
enVVeno Medical Corp
Average Annual Return | -38.46% |
Standard Deviation of Annual Returns | 22.88% |
Max Drawdown | -95% |
Market Capitalization | 66.8m USD |
Shares Outstanding | 13 330 000 |
Percentage of Shares Shorted | 6.81% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 24 full-time employees. The company went IPO on 2018-05-31. The firm is focused on improving the standard of care in the treatment of venous disease. The firm is focused on developing tissue-based solutions that are designed for patients with chronic venous insufficiency (CVI). Its lead product, VenoValve, is a porcine based device being developed to surgically implanted in the deep venous system of the leg to treat severe CVI, including the potential to heal recurring venous leg ulcers. The VenoValve is designed to be implanted into the femoral vein of the patient in an open surgical procedure via a five-to-six-inch incision in the upper thigh. The VenoValve is being evaluated in the surgical anti-reflux venous valve endoprosthesis (SAVVE) United States clinical trial. In addition to the VenoValve, the Company is focused on the development of a second device, enVVe, for the treatment of venous disease.
Contact
IPO
Employees
Officers
The intrinsic value of one NVNO stock under the Base Case scenario is hidden USD.
Compared to the current market price of 5.01 USD, enVVeno Medical Corp is hidden .